Olivier Loeillot

Insider Reports History

Entity
Individual
Location
C/O Repligen Corporation, 41 Seyon Street, Building 1, Suite 100, Waltham, MA
Signature
/s/ Marc Baumgartner (Attorney in Fact)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Olivier Loeillot:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REPLIGEN CORP Chief Executive Officer, Director Common Stock 46.7K $7.31M $156.54 Mar 3, 2025 Direct
REPLIGEN CORP Chief Executive Officer, Director Stock Option (Right to Buy) 13.6K Mar 3, 2025 Direct

Insider Reports Filed by Olivier Loeillot

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGEN REPLIGEN CORP Mar 3, 2025 2 $0 4 Mar 4, 2025 Chief Executive Officer, Director
RGEN REPLIGEN CORP Feb 27, 2025 1 -$53.7K 4 Feb 28, 2025 Chief Executive Officer, Director
RGEN REPLIGEN CORP Nov 20, 2024 1 -$106K 4 Nov 21, 2024 Chief Executive Officer, Director
RGEN REPLIGEN CORP Sep 3, 2024 2 $0 4 Sep 4, 2024 Chief Executive Officer, Director
RGEN REPLIGEN CORP Feb 27, 2024 2 $0 4 Feb 29, 2024 President and CCO
RGEN REPLIGEN CORP Oct 2, 2023 2 $0 4 Oct 3, 2023 President and CCO
RGEN REPLIGEN CORP Oct 2, 2023 0 $0 3 Oct 3, 2023 President and CCO